Nurses satisfied with telehealth in treatment of chronic disease

Nurses working at a home care agency were satisfied with the quality of telehealth services in delivering care to patients managing chronic diseases, according to a study published May 25 in JMIR Informatics.

 

Delivering telehealth nursing care to patients with chronic diseases allows for patients to stay home, cutting cost for both provider and patients. But how due nurses view such services? In this study, researchers examined perceptions of telehealth nursing service quality (TNSQ) to identify if expectations are met.

“One of the evolving roles of nurses as they take on new responsibilities of providing nursing service in home settings is the use of information technology (IT),” wrote first author Ayisha Bashir, MS, MBBS, with the department of clinical and translational science at Creighton University in Omaha, Nebraska, and colleagues. “Although many studies have assessed the cost-effectiveness and patient acceptance of this new method of service delivery, the perspective of nurses as the service provider has not been previously studied.”

The study included survey responses of 13 nurses—all female and most over 35. The survey asked participants to list the positive facilitators of telehealth in improving care quality and potential telehealth barriers to nursing care quality. Results showed positive expectations and perceptions of TNSQ, with the satisfaction of service quality higher than what nurses expected. Nurses pointed out issues with equipment and inconsistency in telehealth equipment were barriers in delivering quality care.

“The responses to the interview questions and data gathered from the survey showed overall satisfaction with TNSQ,” concluded Bashir and colleagues. “In a nutshell, the study highlighted how the telehealth process provides daily monitoring of patient health, leading to the benefits of immediate feedback for patients, family, and caregivers as well as convenience of scheduling.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.